250 related articles for article (PubMed ID: 35747049)
1. Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis.
Tanaka S; Tsuji T; Shiotsu S; Yuba T; Hiraoka N
Cureus; 2022 May; 14(5):e25218. PubMed ID: 35747049
[TBL] [Abstract][Full Text] [Related]
2. Eosinophilic granulomatosis with polyangiitis developed after dupilumab administration in patients with eosinophilic chronic rhinosinusitis and asthma: a case report.
Suzaki I; Tanaka A; Yanai R; Maruyama Y; Kamimura S; Hirano K; Kobayashi H
BMC Pulm Med; 2023 Apr; 23(1):130. PubMed ID: 37076824
[TBL] [Abstract][Full Text] [Related]
3. Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
Wechsler ME; Klion AD; Paggiaro P; Nair P; Staumont-Salle D; Radwan A; Johnson RR; Kapoor U; Khokhar FA; Daizadeh N; Chen Z; Laws E; Ortiz B; Jacob-Nara JA; Mannent LP; Rowe PJ; Deniz Y
J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2695-2709. PubMed ID: 35636689
[TBL] [Abstract][Full Text] [Related]
4. Combination Biologic Therapy with Mepolizumab and Dupilumab for Severe Eosinophilic Granulomatosis with Polyangiitis and Chronic Rhinosinusitis with Nasal Polyp.
Nakamura Y; Kikumoto N; Takeuchi H; Kimura T; Nakamori M; Fujiwara K
Yonago Acta Med; 2024 May; 67(2):157-162. PubMed ID: 38803595
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilia Induced by Blocking the IL-4/IL-13 Pathway: Potential Mechanisms and Clinical Outcomes.
Olaguibel JM; Sastre J; Rodríguez JM; Del Pozo V
J Investig Allergol Clin Immunol; 2022 Jun; 32(3):165-180. PubMed ID: 35522053
[TBL] [Abstract][Full Text] [Related]
6. Severe Asthma Where Eosinophilic Granulomatosis with Polyangiitis Became Apparent after the Discontinuation of Dupilumab.
Ikeda M; Ohshima N; Kawashima M; Shiina M; Kitani M; Suzukawa M
Intern Med; 2022 Mar; 61(5):755-759. PubMed ID: 34393172
[TBL] [Abstract][Full Text] [Related]
7. Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with Asthma.
Kushima Y; Shimizu Y; Hoshi H; Arai R; Ikeda N; Nakamura Y; Masawa M; Okutomi H; Yazawa N; Chibana K; Takemasa A; Niho S
J Clin Med; 2023 Sep; 12(17):. PubMed ID: 37685789
[TBL] [Abstract][Full Text] [Related]
8. Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study.
Molina B; Padoan R; Urban ML; Novikov P; Caminati M; Taillé C; Néel A; Bouillet L; Fraticelli P; Schleinitz N; Christides C; Moi L; Godeau B; Knight A; Schroeder JW; Marchand-Adam S; Gil H; Cottin V; Durel CA; Gelain E; Lerais B; Ruivard M; Groh M; Samson M; Moroni L; Thiel J; Kernder A; Cohen Tervaert JW; Costanzo G; Folci M; Rizzello S; Cohen P; Emmi G; Terrier B
Ann Rheum Dis; 2023 Dec; 82(12):1587-1593. PubMed ID: 37734881
[TBL] [Abstract][Full Text] [Related]
9. Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis.
Nakamoto K; Saraya T; Ogawa Y; Ishii H; Takizawa H
Respir Med; 2018 Jun; 139():101-105. PubMed ID: 29857992
[TBL] [Abstract][Full Text] [Related]
10. Safety of dupilumab in T2 airways conditions: focus on eosinophilia across trials and real-life evidence.
Caminati M; Micheletto C; Norelli F; Olivieri B; Ottaviano G; Padoan R; Piacentini G; Schiappoli M; Senna G; Menzella F
Expert Opin Biol Ther; 2024; 24(1-2):15-23. PubMed ID: 38197326
[TBL] [Abstract][Full Text] [Related]
11. Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids.
Mattsson G; Magnusson P
BMC Cardiovasc Disord; 2017 Dec; 17(1):299. PubMed ID: 29262787
[TBL] [Abstract][Full Text] [Related]
12. Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi.
Adachi S; Oshikata C; Kaneko T; Tsurikisawa N
Allergy Asthma Clin Immunol; 2022 Feb; 18(1):18. PubMed ID: 35219344
[TBL] [Abstract][Full Text] [Related]
13. Last station in the eosinophilic asthma with chronic rhinosinusitis and/or nasal polyposis march: Eosinophilic asthma with radiological findings associated with blood eosinophilia.
Yılmaz I; Bahçecioğlu SN; Türk M; Tutar N; Oymak FS; Gülmez İ
J Asthma; 2019 Feb; 56(2):111-117. PubMed ID: 29611776
[TBL] [Abstract][Full Text] [Related]
14. [Blood eosinophilia in patients with severe bronchial asthma and chronic polypous rhinosinusitis treated with dupilumab: A review].
Petukhova AY; Gromov AS; Solovyov RV; Filippova SG; Prokopieva ER
Ter Arkh; 2024 Apr; 96(3):303-308. PubMed ID: 38713048
[TBL] [Abstract][Full Text] [Related]
15. Asthma Control and Airway Inflammation in Patients with Eosinophilic Granulomatosis with Polyangiitis.
Latorre M; Baldini C; Seccia V; Pepe P; Novelli F; Celi A; Bacci E; Cianchetti S; Dente FL; Bombardieri S; Paggiaro P
J Allergy Clin Immunol Pract; 2016; 4(3):512-9. PubMed ID: 26883543
[TBL] [Abstract][Full Text] [Related]
16. Retrospective comparison of high-resolution computed tomography of eosinophilic granulomatosis with polyangiitis with severe asthma.
Lin X; Lin Y; Lai Z; Wei S; Qiu M; Li J; Liu Q; Chung KF; Zeng Q; Zhang Q
Ann Transl Med; 2021 Jun; 9(12):983. PubMed ID: 34277783
[TBL] [Abstract][Full Text] [Related]
17. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
18. How Can Dupilumab Cause Eosinophilic Pneumonia?
Kurihara M; Masaki K; Matsuyama E; Fujioka M; Hayashi R; Tomiyasu S; Sasahara K; Sunata K; Asaoka M; Akiyama Y; Nishie M; Irie M; Tanosaki T; Kabata H; Fukunaga K
Biomolecules; 2022 Nov; 12(12):. PubMed ID: 36551171
[TBL] [Abstract][Full Text] [Related]
19. Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
Berti A; Volcheck GW; Cornec D; Smyth RJ; Specks U; Keogh KA
Respir Med; 2018 Sep; 142():66-72. PubMed ID: 30170804
[TBL] [Abstract][Full Text] [Related]
20. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.
Detoraki A; Tremante E; Poto R; Morelli E; Quaremba G; Granata F; Romano A; Mormile I; Rossi FW; de Paulis A; Spadaro G
Respir Res; 2021 Jun; 22(1):185. PubMed ID: 34162391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
